Long-term Polynovo shareholders see relief as US Medicare changes offer boon
Healthcare player Polynovo (ASX:PNV) has offered relief to long-term shareholders who may have been bemoaning 1Y returns down -30%.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FNZ | Ann: FNZ NTA 02-09-2025 $3.15899 | 07:58 | 0 | 18 | |||
|
|||||||
FNZ | Ann: FNZ NTA 01-09-2025 $3.14400 | 02/09/25 | 0 | 37 | |||
|
|||||||
FNZ | Ann: FNZ NTA 29-08-2025 $3.11090 | 01/09/25 | 0 | 28 | |||
|
|||||||
FNZ | Ann: FNZ NTA 28-08-2025 $3.09570 | 29/08/25 | 0 | 31 | |||
|
|||||||
FNZ | Ann: FNZ NTA 27-08-2025 $3.07743 | 28/08/25 | 0 | 29 | |||
|
|||||||
FNZ | Ann: FNZ NTA 26-08-2025 $3.09847 | 27/08/25 | 0 | 36 | |||
|
|||||||
FNZ | Ann: FNZ NTA 25-08-2025 $3.12158 | 26/08/25 | 0 | 56 | |||
|
|||||||
FNZ | Ann: FNZ NTA 22-08-2025 $3.11057 | 25/08/25 | 0 | 39 | |||
|
See All Discussions